Last updated: May 04, 2026

Application No. 17/917,651

RECOMBINANT VACCINES AND METHODS OF USE THEREOF

Non-Final OA

Filed

Oct 07, 2022

Priority

Apr 10, 2020 — provisional 63/007,985 +2 more

Examiner

BELYAVSKYI, MICHAIL A

Art Unit

1644

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

VANDERBILT UNIVERSITY

OA Round

1 (Non-Final)

This examiner grants 64% of cases after interview

— +27.1% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1093 resolved cases, 2023–2026

Examiner Intelligence

BELYAVSKYI, MICHAIL A View full profile →

Grants 64% of resolved cases

Career Allowance Rate

699 granted / 1093 resolved

+4.0% vs TC avg

Strong +27% interview lift

Without

With

+27.1%

Interview Lift

resolved cases with interview

Typical timeline

3y 1m

Avg Prosecution

78 currently pending

Career history

1171

Total Applications

across all art units

Statute-Specific Performance

§101

2.3%

-37.7% vs TC avg

§103

29.0%

-11.0% vs TC avg

§102

9.6%

-30.4% vs TC avg

§112

10.9%

-29.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1093 resolved cases

Prosecution Timeline

Oct 07, 2022

Application Filed

Aug 16, 2024

Response after Non-Final Action

Sep 03, 2025

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/047,516

Patent 12612602

PRODUCTION OF A BIOENGINEERED LUNG

5y 6m to grant Granted Apr 28, 2026

17/110,179

Patent 12611428

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

5y 4m to grant Granted Apr 28, 2026

17/817,247

Patent 12611429

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

3y 8m to grant Granted Apr 28, 2026

16/566,610

Patent 12605432

Novel Combinations for Antigen Based Therapy

6y 7m to grant Granted Apr 21, 2026

18/000,096

Patent 12599675

NOVEL CONJUGATE OF IMMUNE-STIMULATING IL-2 ANALOG AND PREPARATION METHOD THEREOF

3y 4m to grant Granted Apr 14, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

64%

Grant Probability

91%

With Interview (+27.1%)

3y 1m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1093 resolved cases by this examiner. Grant probability derived from career allowance rate.